Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azyter vs tobramycin in pediatric purulent bacterial conjunctivitis
2008-003567-39Phase 3Completed
- Sponsor
- Laboratoires Théa
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of azithromycin in bacterial conjunctivitis (BC) (2 arms), sponsored by Laboratoires Théa. Primary endpoint: Clinical cure at Day 3. Started Jun 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on 2008-003567-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003567-39.